BCR activation provides survival and proliferative signals for CLL cells, and responsiveness to BCR triggering is higher in IGHV-unmutated than in IGHV-mutated cells, thus explaining the impact of IGHV SHM status on CLL progression and prognosis [68]. Here, BCR is linked to B-cell chronic lymphocytic leukemia.